BEIJING BEILU PHARMACEUTICAL
Beijing Beilu Pharmaceutical mainly engaged in the research and development, production, and sales of pharmaceutical products. It is a national high-tech enterprise, one of the first batch of listed enterprises in Growth Enterprises Market (stock code 300016), and a leading contrast agent enterprise. Beilu is the first company to develop and launch the contrast agent products in China, filling the gap in the domestic market, and forming a unique core competitive advantage in this field is the market leader in the domestic contrast agent industry. In addition, the company has also strengthened R&D in the field of psychoneurosis and endocrinology drugs, and strive to achieve variety diversification.
BEIJING BEILU PHARMACEUTICAL
Social Links:
Founded:
1992-01-01
Status:
Active
Total Funding:
9.7 M USD
Technology used in webpage:
Euro Pound Sterling Japanese Yen Chinese Server Location
Similar Organizations
Hunan Nucien Pharmaceutical
Hunan Nucien engages in the research and development, production, and sale of pharmaceutical product
Stock Details
Investors List
Infotech Ventures
Infotech Ventures investment in Private Equity Round - Beijing Beilu Pharmaceutical
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2016-06-01 | Geneseeq | Beijing Beilu Pharmaceutical investment in Series B - Geneseeq | 60 M CNY |
| 2014-08-01 | Geneseeq | Beijing Beilu Pharmaceutical investment in Series A - Geneseeq | 30 M CNY |